Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: The rancho bernardo study

Journal of Urology

Volumn 184, Issue 3, 2010, Pages 1040-1044

  Parsons, J Kellogg ^a,b   Palazzi Churas, Kerrin ^a   Bergstrom, Jaclyn ^c   Barrett Connor, Elizabeth ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholestenone 5 alpha reductase; Dihydrotestosterone; Prostate; Prostatic hyperplasia; Urination disorders

Indexed keywords

ANDROSTANOLONE; CHOLESTENONE 5ALPHA REDUCTASE; DUTASTERIDE; ESTRADIOL; FINASTERIDE; PRASTERONE SULFATE; STEROID 5ALPHA REDUCTASE INHIBITOR; STEROID HORMONE; TESTOSTERONE;

ADULT; AGING; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; HORMONE BLOOD LEVEL; HUMAN; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; RISK ASSESSMENT; SERUM; SURVIVOR; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

DIHYDROTESTOSTERONE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; RISK FACTORS; TIME FACTORS;

EID: 77955712006     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.05.033     Document Type: Article

References (28)

1. J.T. Wei, E. Calhoun, and S.J. Jacobsen Urologic Diseases in America Project: benign prostatic hyperplasia J Urol 173 2005 1256
2. G. Engstrom, L. Henningsohn, and G. Steineck Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract BJU Int 95 2005 810
3. G. Engstrom, L. Henningsohn, and M.L. Walker-Engstrom Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire Scand J Urol Nephrol 40 2006 485
4. B.C. Taylor, T.J. Wilt, and H.A. Fink Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study Urology 68 2006 804
5. J.K. Parsons, J. Mougey, and L. Lambert Lower urinary tract symptoms increase the risk of falls in older men BJU Int 2009
6. F.H. Schroeder, M. Westerhof, and R.J. Bosch Benign prostatic hyperplasia treated by castration or the LH-RH analogue buserelin: a report on 6 cases Eur Urol 12 1986 318
7. J.K. Parsons, J. Bergstrom, and J. Silberstein Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years Urology 72 2008 318
8. S.M. Harman, E.J. Metter, and J.D. Tobin Longitudinal effects of aging on serum total and free testosterone levels in healthy men Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86 2001 724
9. A.R. Kristal, J.M. Schenk, and Y. Song Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial Am J Epidemiol 168 2008 1416
10. Y. Miwa, T. Kaneda, and O. Yokoyama Association between lower urinary tract symptoms and serum levels of sex hormones in men Urology 72 2008 552
11. C.C. Liu, C.J. Wang, and S.P. Huang Relationships between American Urological Association symptom index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia Kaohsiung J Med Sci 20 2004 273
12. S. Rohrmann, W.G. Nelson, and N. Rifai Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) Urology 69 2007 708
13. R.O. Roberts, D.J. Jacobson, and T. Rhodes Serum sex hormones and measures of benign prostatic hyperplasia Prostate 61 2004 124
14. J.B. Meigs, B. Mohr, and M.J. Barry Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 2001 935
15. P.H. Gann, C.H. Hennekens, and C. Longcope A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia Prostate 26 1995 40
16. M.O. Tan, I. Karabiyik, and M.C. Uygur Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia Int Urol Nephrol 35 2003 357
17. G. Schatzl, C. Brossner, and S. Schmid Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function The Prostate Study Group of the Austrian Society of Urology. Urology 55 2000 397
18. E.A. Platz, I. Kawachi, and E.B. Rimm Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms Prostate Cancer Prostatic Dis 2 1999 285
19. H.J. Litman, S. Bhasin, and M.P. O'Leary An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health Survey BJU Int 100 2007 321
20. E.L. Barrett-Connor, B.A. Cohn, and D.L. Wingard Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study JAMA 265 1991 627
21. R.R. Tremblay, and J.Y. Dube Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives Contraception 10 1974 599
22. E. Giovannucci, E.B. Rimm, and C.G. Chute Obesity and benign prostatic hyperplasia Am J Epidemiol 140 1994 989
23. D. Kang, G.L. Andriole, and C. Van DeVooren Risk behaviours and benign prostatic hyperplasia BJU Int 93 2004 1241
24. R.J. Glynn, E.W. Campion, and G.R. Bouchard The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study Am J Epidemiol 121 1985 78
25. J.K. Parsons, J. Bergstrom, and E. Barrett-Connor Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men BJU Int 101 2008 313
26. S. Bhasin, A.B. Singh, and R.P. Mac Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan J Androl 24 2003 299
27. C.C. Liu, S.P. Huang, and W.M. Li Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men Urology 70 2007 677
28. J.K. Amory, C. Wang, and R.S. Swerdloff The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men J Clin Endocrinol Metab 92 2007 1659